Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_assertion type Assertion NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_head.
- NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_provenance.
- NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_assertion evidence source_evidence_literature NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_provenance.
- NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_assertion SIO_000772 22773603 NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_provenance.
- NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_assertion wasDerivedFrom befree-20150227 NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_provenance.
- NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_assertion wasGeneratedBy ECO_0000203 NP914144.RAC0j0ziKQpNZNLvF1E38QczOCww9e6wP4CZ_BmaoXgpk130_provenance.